Study of Synergistic Anticancer Mechanism of Combination Treatment between Sildenafil and Doxorubicin in Hormone-Refractory Prostate Cancer – Crucial Role of Dna Repair and Development of Sildenafil Derivatives without Cardiovascular Adverse Effects

2019-08-012024-05-17https://scholars.lib.ntu.edu.tw/handle/123456789/678865Study of Synergistic Anticancer Mechanism of Combination Treatment between Sildenafil and Doxorubicin in Hormone-Refractory Prostate Cancer – Crucial Role of Dna Repair and Development of Sildenafil Derivatives without Cardiovascular Adverse Effects